MD411C2 - Process for obtaining the pancreatic from the pancreas - Google Patents
Process for obtaining the pancreatic from the pancreasInfo
- Publication number
- MD411C2 MD411C2 MD95-0074A MD950074A MD411C2 MD 411 C2 MD411 C2 MD 411C2 MD 950074 A MD950074 A MD 950074A MD 411 C2 MD411 C2 MD 411C2
- Authority
- MD
- Moldova
- Prior art keywords
- alcohol
- isoprophylic
- autolysis
- filtrated
- pancreas
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 210000000496 pancreas Anatomy 0.000 title abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 3
- 208000035404 Autolysis Diseases 0.000 abstract 2
- 206010057248 Cell death Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 238000004062 sedimentation Methods 0.000 abstract 2
- 230000028043 self proteolysis Effects 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 235000013372 meat Nutrition 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/94—Pancreatin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to medicine, namely, to remedies preparation.The aim of the invention - desired high activity products yield increasing.The congelated pig's pancreas are reduced to fragments, grinded with the meat grinder, conducted to autolysis at (-2)-(+30)°C and pH 6,5-8,5.In parallel the sedimentation test is analyzed each 15 min water isoprophylic alcohol solution 55-65%. At achieving the autolysus sedimentation speed of 3-10 mm during 1-3 min the autolysis is broken off by addition of the isoprophylic alcohol up to the final concentration of 30-35%, then it is filtrated through the sieve. In the obtained solution there is added isporopylic alcohol at the concentration of 75-95%. the suspension is filtrated with he nutsch-filter having diameter of 40 cm and is settled for drying in the vacuum at 55°C and pression of 4 mbar. The process allows the high activity desired product yield increasing.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823248588 DE3248588A1 (en) | 1982-12-30 | 1982-12-30 | Process for obtaining pancreatin with high apparent density |
| DE19823248587 DE3248587A1 (en) | 1982-12-30 | 1982-12-30 | Process for obtaining pancreatin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MD411C2 true MD411C2 (en) | 1996-06-30 |
Family
ID=25807022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MD95-0074A MD411C2 (en) | 1982-12-30 | 1994-12-29 | Process for obtaining the pancreatic from the pancreas |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4623624A (en) |
| EP (1) | EP0115023B1 (en) |
| AR (1) | AR232000A1 (en) |
| BR (1) | BR8307280A (en) |
| CA (1) | CA1208580A (en) |
| DD (1) | DD212981A5 (en) |
| DE (1) | DE3377506D1 (en) |
| DK (1) | DK173599B1 (en) |
| ES (1) | ES8407516A1 (en) |
| HU (1) | HU196435B (en) |
| MD (1) | MD411C2 (en) |
| PL (1) | PL141118B1 (en) |
| SU (1) | SU1644712A3 (en) |
| UA (1) | UA5996A1 (en) |
| YU (1) | YU45584B (en) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH30058A (en) * | 1989-11-24 | 1996-11-08 | Biochemie Gmbh | Pancreation preparations |
| CA2198317C (en) * | 1997-02-24 | 2003-01-07 | Mouhsine El Abboudi | Method for preparing pancreatin which contains low amounts of residual organic solvent and product thereof |
| US6632429B1 (en) | 1999-12-17 | 2003-10-14 | Joan M. Fallon | Methods for treating pervasive development disorders |
| KR100367659B1 (en) * | 2000-05-08 | 2003-01-14 | 주식회사 바이넥스 | The method of preparing pancreatin by adding selective stabilizers |
| US20070053895A1 (en) | 2000-08-14 | 2007-03-08 | Fallon Joan M | Method of treating and diagnosing parkinsons disease and related dysautonomic disorders |
| IT1319655B1 (en) | 2000-11-15 | 2003-10-23 | Eurand Int | PANCREATIC ENZYME MICROSPHERES WITH HIGH STABILITY AND RELATIVE PREPARATION METHOD. |
| US8030002B2 (en) | 2000-11-16 | 2011-10-04 | Curemark Llc | Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions |
| CA2419572A1 (en) * | 2003-02-18 | 2004-08-18 | Axcan Pharma Inc. | High dosage protease formulation |
| AU2004260961B2 (en) * | 2003-07-29 | 2010-05-20 | Abbott Laboratories Gmbh | Analytical method for pancreatin and comparable compositions |
| ES2314646T3 (en) * | 2004-03-22 | 2009-03-16 | Solvay Pharmaceuticals Gmbh | PHARMACEUTICAL COMPOSITIONS VIA PRODUCTS CONTAINING LIPASE, IN PARTICULAR PANCREATIN, CONTAINING TENSIOACTIVE. |
| US7153504B2 (en) * | 2004-07-30 | 2006-12-26 | Can Technologies, Inc. | Stabilized pancreas product |
| CN101184780B (en) | 2005-05-05 | 2012-10-03 | 森馨香料公司 | Preparation of β-glucan and mannan |
| HUE031042T2 (en) | 2005-07-29 | 2017-06-28 | Abbott Laboratories Gmbh | Processes for the manufacture of pancreatin powder with low virus content |
| US11266607B2 (en) * | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
| US9198871B2 (en) * | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
| US20080058282A1 (en) | 2005-08-30 | 2008-03-06 | Fallon Joan M | Use of lactulose in the treatment of autism |
| TW200745337A (en) * | 2006-02-24 | 2007-12-16 | Aminotech As | Modified process |
| US10072256B2 (en) * | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
| AU2008218595B2 (en) | 2007-02-20 | 2012-05-24 | Allergan Therapeutics LLC | Stable digestive enzyme compositions |
| US20090130063A1 (en) * | 2007-11-15 | 2009-05-21 | Solvay Pharmaceuticals Gmbh | Process for separating and determining the viral load in a pancreatin sample |
| WO2009109856A2 (en) | 2008-03-07 | 2009-09-11 | Axcan Pharma Inc. | Method for detecting infectious parvovirus in pharmaceutical preparations |
| US8658163B2 (en) | 2008-03-13 | 2014-02-25 | Curemark Llc | Compositions and use thereof for treating symptoms of preeclampsia |
| US8084025B2 (en) | 2008-04-18 | 2011-12-27 | Curemark Llc | Method for the treatment of the symptoms of drug and alcohol addiction |
| US9320780B2 (en) | 2008-06-26 | 2016-04-26 | Curemark Llc | Methods and compositions for the treatment of symptoms of Williams Syndrome |
| ES2732453T3 (en) | 2008-07-01 | 2019-11-22 | Curemark Llc | Methods and compositions for the treatment of symptoms of neurological and mental health disorders |
| US10776453B2 (en) | 2008-08-04 | 2020-09-15 | Galenagen, Llc | Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain |
| EP2165717A1 (en) * | 2008-08-27 | 2010-03-24 | Nordmark Arzneimittel GmbH & Co.KG | Method for reducing viral and microbial load on biological extracts containing solids |
| US20100092447A1 (en) | 2008-10-03 | 2010-04-15 | Fallon Joan M | Methods and compositions for the treatment of symptoms of prion diseases |
| JP2012514604A (en) | 2009-01-06 | 2012-06-28 | キュレロン リミテッド ライアビリティ カンパニー | Compositions and methods for the treatment or prevention of oral infection by E. coli |
| CA3050530A1 (en) | 2009-01-06 | 2010-07-15 | Galenagen, Llc | Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces |
| US9056050B2 (en) | 2009-04-13 | 2015-06-16 | Curemark Llc | Enzyme delivery systems and methods of preparation and use |
| US9511125B2 (en) | 2009-10-21 | 2016-12-06 | Curemark Llc | Methods and compositions for the treatment of influenza |
| UA111726C2 (en) | 2010-10-01 | 2016-06-10 | Апталіс Фарма Лімітед | LOW FORCE PANCRELIPASE PREPARATION WITH INTRA-SOLID COVERING |
| MX362974B (en) | 2011-04-21 | 2019-02-28 | Curemark Llc | Compounds for the treatment of neuropsychiatric disorders. |
| MX351014B (en) | 2011-08-08 | 2017-09-28 | Aptalis Pharma Ltd | Method for dissolution testing of solid compositions containing digestive enzymes. |
| US10350278B2 (en) | 2012-05-30 | 2019-07-16 | Curemark, Llc | Methods of treating Celiac disease |
| US10184121B2 (en) | 2013-06-28 | 2019-01-22 | Allergan Pharmaceuticals International Limited | Methods for removing viral contaminants from pancreatic extracts |
| US20160152968A1 (en) * | 2013-07-22 | 2016-06-02 | Aptalis Pharma Ltd. | High potency pancreatin pharmaceutical compositions |
| US20160108389A1 (en) * | 2013-07-22 | 2016-04-21 | Aptalis Pharma Ltd. | High potency pancreatin pharmaceutical compositions |
| CN106163544A (en) | 2013-08-09 | 2016-11-23 | 阿勒根制药国际有限公司 | Digestive enzyme composition suitable for enteral administration |
| CN106659773A (en) * | 2013-11-05 | 2017-05-10 | 阿勒根制药国际有限公司 | High potency pancreatin pharmaceutical compositions |
| MX391630B (en) | 2014-11-05 | 2025-03-19 | Abbott Laboratories Gmbh | PROCESSES FOR THE PRODUCTION OF COMPOSITIONS WITH IMPROVED SAFETY PROFILE HAVING LIPASE ACTIVITY AND COMPOSITIONS SUITABLE FOR MEDICINES |
| ES2970869T3 (en) | 2016-03-28 | 2024-05-31 | Abbott Laboratories Gmbh | Enzymatic compositions with reduced viral and microbial contamination |
| US11278603B2 (en) | 2016-03-28 | 2022-03-22 | Abbvie Inc. | Enzyme compositions with reduced viral and microbial contamination |
| AU2018250823A1 (en) | 2017-04-10 | 2019-10-17 | Curemark, Llc | Compositions for treating addiction |
| EA202090851A1 (en) | 2017-09-27 | 2020-08-07 | Эбботт Лэбораториз Гмбх | ENZYME COMPOSITIONS WITH A REDUCED LEVEL OF VIRAL AND MICROBIAL CONTAMINATION |
| CN108316036A (en) * | 2018-01-25 | 2018-07-24 | 陕西科技大学 | A kind of method that bean dregs prepare fento cellulose |
| US11541009B2 (en) | 2020-09-10 | 2023-01-03 | Curemark, Llc | Methods of prophylaxis of coronavirus infection and treatment of coronaviruses |
| WO2024105193A1 (en) * | 2022-11-17 | 2024-05-23 | Koptyug Andrey V | Novel compounds and methods |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3223594A (en) * | 1960-10-25 | 1965-12-14 | Philips Corp | Method of producing pancreatin |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1328202A (en) | 1969-06-17 | 1973-08-30 | Union International Co Ltd | Manufacture of pancreatin |
| DE2106706B2 (en) * | 1971-02-12 | 1973-05-10 | Wilson Pharmaceutical & Chemical Corp., Chicago, 111. (V.St.A.) | METHOD FOR MANUFACTURING PANCREATIN AS A DRY POWDER WITH HIGH PROTEOLYTIC, AMYLOLYTIC AND LIPOLYTIC ACTIVITY |
| DE2620289C2 (en) * | 1976-05-07 | 1982-05-19 | A. Nattermann & Cie GmbH, 5000 Köln | Production of a lipase-rich enzyme preparation |
| US4088539A (en) | 1976-05-07 | 1978-05-09 | A. Nattermann & Cie Gmbh | Process of manufacturing enzyme preparation rich in lipase |
-
1983
- 1983-12-20 DE DE8383112809T patent/DE3377506D1/en not_active Expired
- 1983-12-20 EP EP83112809A patent/EP0115023B1/en not_active Expired
- 1983-12-23 US US06/565,220 patent/US4623624A/en not_active Expired - Lifetime
- 1983-12-28 CA CA000444332A patent/CA1208580A/en not_active Expired
- 1983-12-28 YU YU252483A patent/YU45584B/en unknown
- 1983-12-28 AR AR295280A patent/AR232000A1/en active
- 1983-12-28 PL PL1983245381A patent/PL141118B1/en unknown
- 1983-12-29 DD DD83258863A patent/DD212981A5/en not_active IP Right Cessation
- 1983-12-29 SU SU833682185A patent/SU1644712A3/en active
- 1983-12-29 BR BR8307280A patent/BR8307280A/en not_active IP Right Cessation
- 1983-12-29 HU HU834516A patent/HU196435B/en not_active IP Right Cessation
- 1983-12-29 UA UA3682185A patent/UA5996A1/en unknown
- 1983-12-29 ES ES528537A patent/ES8407516A1/en not_active Expired
- 1983-12-29 DK DK198306055A patent/DK173599B1/en not_active IP Right Cessation
-
1994
- 1994-12-29 MD MD95-0074A patent/MD411C2/en unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3223594A (en) * | 1960-10-25 | 1965-12-14 | Philips Corp | Method of producing pancreatin |
Also Published As
| Publication number | Publication date |
|---|---|
| DE3377506D1 (en) | 1988-09-01 |
| YU45584B (en) | 1992-07-20 |
| ES528537A0 (en) | 1984-09-16 |
| PL245381A1 (en) | 1984-10-22 |
| DK605583A (en) | 1984-07-01 |
| DK605583D0 (en) | 1983-12-29 |
| DK173599B1 (en) | 2001-04-23 |
| EP0115023A2 (en) | 1984-08-08 |
| EP0115023A3 (en) | 1986-04-09 |
| HU196435B (en) | 1988-11-28 |
| AR232000A1 (en) | 1985-04-30 |
| PL141118B1 (en) | 1987-06-30 |
| UA5996A1 (en) | 1994-12-29 |
| US4623624A (en) | 1986-11-18 |
| BR8307280A (en) | 1984-08-07 |
| ES8407516A1 (en) | 1984-09-16 |
| CA1208580A (en) | 1986-07-29 |
| DD212981A5 (en) | 1984-08-29 |
| EP0115023B1 (en) | 1988-07-27 |
| YU252483A (en) | 1986-10-31 |
| SU1644712A3 (en) | 1991-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA5996A1 (en) | METHOD OF OBTAINING PANCREOTIN FROM THE PANCREAS | |
| EP0171086B1 (en) | A method for purification of influenza virus | |
| RO90639B (en) | Process for preparing a human tissue plasminogene activator | |
| SE9302996D0 (en) | Homogeneous and stable cereal suspension | |
| US4793996A (en) | Method of making soybean extract inhibitor | |
| GB1537509A (en) | Method of preparing a component consisting of sugar lipid and protein derived from pseudomonas aeruginosa which possesses anti-tumor and interferon-inducing properties | |
| Yamasaki et al. | Purification and crystallization of α-glucosidase from Mucor javanicus | |
| EP0116232B1 (en) | Antitumor agent and process for manufacturing said agent | |
| GB1575545A (en) | Tumour antigen and process for the preparation thereof | |
| US2808362A (en) | Preparation of hyaluronidase | |
| EP0110688B1 (en) | Angiogenic factor production | |
| FR2672895A1 (en) | PROCESS FOR THE PURIFICATION OF A HIGHLY GLYCOSYLATED PROTEIN. | |
| EP0301374A2 (en) | Process for the purification of the placenta tissue protein PP4 | |
| US4136168A (en) | Process for the preparation of neuraminidase from viral sources and methods of utilizing same | |
| RU2041715C1 (en) | Biologically active remedy, method for its producing, preparation containing the mentioned remedy and method for applying the preparation | |
| Loos et al. | Cell-wall-bound lytic activity in Chlorella fusca: function and characterization of an endo-mannanase | |
| Kurosaki et al. | Phytoalexin production in cultured carrot cells treated with pectinolytic enzymes | |
| US3660238A (en) | Extraction of asparaginase from bacterial culture | |
| JP3331870B2 (en) | Method for producing water-soluble polysaccharide | |
| Oleson et al. | Nuclease I from suspension-cultured Nicotiana tabacum: purification and properties of the extracellular enzyme | |
| Cw et al. | Chlorophyll-proteins from Acetabularia mediterranea | |
| Hurst | A rapid method for the large scale preparation of calf thymus deoxyribonucleate | |
| US4495096A (en) | Process for producing and obtaining anaphylatoxin-and cocytotaxin-containing leucotaxine preparations and of anaphylatoxin and cocytotaxin proteins in molecularly homogeneous, biologically active form | |
| JP3683912B2 (en) | Cell composition | |
| RU2130070C1 (en) | Method of peroxidase preparing |